Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:35282117

Analysis of cancer-promoting genes related to chemotherapy resistance in esophageal squamous cell carcinoma.

Feng Xie · Donglei Zhang · Xiaoqing Qian · Huabing Wei · Lihuang Zhou · Chunyong Ding · Wenbiao Pan · Qing Ye

Annals of translational medicine · 2022 doi:10.21037/atm-21-7032

Paper

complete

Experiment

complete

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:35282117
kind
science-record
content_hash
sha256:8e37b32070429b65bf6f06da6c30fa3342fd7e3ab8ec33b644671a7d9763f608
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T18:14:04Z
updated_at
2026-11-01T22:06:06Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Analysis of cancer-promoting genes related to chemotherapy resistance in esophageal squamous cell carcinoma.
doi
10.21037/atm-21-7032
pmid
35282117
authors array · 8 items
[0]
Feng Xie
[1]
Donglei Zhang
[2]
Xiaoqing Qian
[3]
Huabing Wei
[4]
Lihuang Zhou
[5]
Chunyong Ding
[6]
Wenbiao Pan
[7]
Qing Ye
journal
Annals of translational medicine
year
2022
abstract
Background: According to histopathology, esophageal cancer can be divided into squamous cell carcinoma (SCC) and esophageal adenocarcinoma (adeno arcinoma). In China, 90% of esophageal cancer patients are squamous cell carcinoma. Cisplatin and fluaziridine are the main chemotherapy before and after surgery. Long-term drug treatment is often accompanied by the emergence of drug resistance of tumor cells. There are many mechanisms for the emergence of drug resistance of tumor cells, including the increase of drug efflux, the decrease of drug intake, the inhibition of cell apoptosis, and so on. This study aimed to investigate the key cancer-promoting genes related to chemotherapy resistance in esophageal squamous cell carcinoma (ESCC). Methods: Two datasets from the Gene Expression Omnibus (GEO) database (GSE86099 and GSE50224) were retrieved. We performed microRNA (miRNA) and messenger RNA (mRNA) expression analysis to identify differentially expressed genes (DEGs). The intersection of the downregulated miRNA targets and the upregulated mRNAs were used for Gene Ontology (GO) enrichment analysis, and survival risk was assessed using data from The Cancer Genome Atlas (TCGA). Results: There were 35 common genes, of which, based on GO enrichment, most were related to the cardiac muscle cell action. Four genes showed significant association with the estimated half-maximal inhibitory concentration (IC50) of paclitaxel: bone morphogenetic protein 1 (BMP1), dumbbell former 4 protein (DBF4), angiogenin (ANG), and MAP7 domain containing 2 (MAP7D2). Four risk factors (MP1, HIP1, ANG, and MAP7D2) were selected to generate a signature using least absolute shrinkage and selection operator (LASSO) regression. Protein-protein interaction (PPI) analysis showed guanine nucleotide-binding protein subunit beta 4 (GNB4), calcium voltage-gated channel auxiliary subunit beta 2 (CACNB2), and sodium voltage-gated channel alpha subunit 1 (SCN1A) were located at key positions of the network. Among potential risk genes, only the high expression of dedicator of cytokinesis 8 (DOCK8) was associated with poorer survival. Conclusions: The 35 oncogenes may be involved in mechanisms of chemotherapy resistance in ESCC, as well as the corresponding enrichment and regulatory network. The signature containing 4 key risk genes merits further investigation and may provide a deeper understanding of the molecular mechanisms in ESCC treatment failure.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
After screening the essential ESCC-associated genes involved in both chemotherapy resistance and survival, least absolute shrinkage and selection operator (LASSO) Cox regression was performed to identify relevant risk genes, using 10-fold cross-validation, and the prognostic predictive signature, using the R software package glmnet (v 4.1-1).
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35282117
locator
sections[7] "Prognostic predictive signature" paragraph 2
quote
After screening the essential ESCC-associated genes involved in both chemotherapy resistance and survival, least absolute shrinkage and selection operator (LASSO) Cox regression was performed to identify relevant risk genes, using 10-fold cross-validation, and the prognostic predictive signature, using the R software package glmnet (v 4.1-1).
state
complete
[1] object · 6 fields
id
claim-data-access
statement
There were two available arrays with chemotherapy-resistant ESCC samples: GSE86099 (gene expression signature of paclitaxel resistance in human ESCC cell lines) and GSE50224 (the expression profiling of miRNA from chemotherapy-resistant esophageal adenosquamous carcinoma cell line).
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35282117
locator
sections[3] "Microarray data" paragraph 3
quote
There were two available arrays with chemotherapy-resistant ESCC samples: GSE86099 (gene expression signature of paclitaxel resistance in human ESCC cell lines) and GSE50224 (the expression profiling of miRNA from chemotherapy-resistant esophageal adenosquamous carcinoma cell line).
state
complete
[2] object · 6 fields
id
claim-target-result
statement
The four-gene risk signature achieved an AUC of 0.856 for 2-year survival prediction.
kind
quantitative
target object · 4 fields
value
95
unit
per cent
tolerance
null
source
In particular, the AUC value for the 2-year survival evaluation was 0.856 (95% CI: 0.742−0.969).
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35282117
locator
sections[17] "Prognostic performance of the signature" paragraph 2
quote
In particular, the AUC value for the 2-year survival evaluation was 0.856 (95% CI: 0.742−0.969).
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
The four-gene risk signature achieved an AUC of 0.856 for 2-year survival prediction.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:35282117
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE50224
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE50224
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 3 items
[0] object · 15 fields
id
source:pmid:35282117
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.21037/atm-21-7032
sha256
sha256:545ee8603e691e1eba6cac667861c21b2e60a5c0503aaf7bdeb9edc158b12a08
bytes
39042
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.21037/atm-21-7032
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC8848450
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE50224
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE50224
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE50224
version
null
note
There were two available arrays with chemotherapy-resistant ESCC samples: GSE86099 (gene expression signature of paclitaxel resistance in human ESCC cell lines) and GSE50224 (the expression profiling of miRNA from chemotherapy-resistant esophageal adenosquamous carcinoma cell line).
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
There were two available arrays with chemotherapy-resistant ESCC samples: GSE86099 (gene expression signature of paclitaxel resistance in human ESCC cell lines) and GSE50224 (the expression profiling of miRNA from chemotherapy-resistant esophageal adenosquamous carcinoma cell line).
access_statement_kind
repository_route_statement
sample_accessions array · 36 items
[0]
GSM1216060
[1]
GSM1216061
[2]
GSM1216062
[3]
GSM1216063
[4]
GSM1216064
[5]
GSM1216065
[6]
GSM1216066
[7]
GSM1216067
[8]
GSM1216068
[9]
GSM1216069
[10]
GSM1216070
[11]
GSM1216071
[12]
GSM1216072
[13]
GSM1216073
[14]
GSM1216074
[15]
GSM1216075
[16]
GSM1216076
[17]
GSM1216077
[18]
GSM1216078
[19]
GSM1216079
[20]
GSM1216080
[21]
GSM1216081
[22]
GSM1216082
[23]
GSM1216083
[24]
GSM1216084
[25]
GSM1216085
[26]
GSM1216086
[27]
GSM1216087
[28]
GSM1216088
[29]
GSM1216089
[30]
GSM1216090
[31]
GSM1216091
[32]
GSM1216092
[33]
GSM1216093
[34]
GSM1216094
[35]
GSM1216095
sample_count
36
group_sizes
null
group_sizes_basis
null
platform
8786
taxon
synthetic construct; Homo sapiens
title
MIcroRNA expression profiling of chemotherapy resistant esophageal adeno- and squamous cell carcinoma cell lines
resolution_checked_at
2026-11-01T18:06:44Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 15 fields
id
data:geo:GSE86099
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE86099
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE86099
version
null
note
There were two available arrays with chemotherapy-resistant ESCC samples: GSE86099 (gene expression signature of paclitaxel resistance in human ESCC cell lines) and GSE50224 (the expression profiling of miRNA from chemotherapy-resistant esophageal adenosquamous carcinoma cell line).
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
There were two available arrays with chemotherapy-resistant ESCC samples: GSE86099 (gene expression signature of paclitaxel resistance in human ESCC cell lines) and GSE50224 (the expression profiling of miRNA from chemotherapy-resistant esophageal adenosquamous carcinoma cell line).
access_statement_kind
repository_route_statement
sample_accessions array · 4 items
[0]
GSM2293542
[1]
GSM2293543
[2]
GSM2293544
[3]
GSM2293545
sample_count
4
group_sizes
null
group_sizes_basis
null
platform
4133
taxon
Homo sapiens
title
Gene expression signature of paclitaxel resistance in human esophageal squamous cell cancer cell line
resolution_checked_at
2026-11-01T15:39:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 4 items
[0]
asset:data:geo:GSE50224 not downloaded
[1]
asset:data:geo:GSE50224 licence not read
[2]
asset:data:geo:GSE86099 not downloaded
[3]
asset:data:geo:GSE86099 licence not read
analysis object · 4 fields
state
complete
methods array · 5 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
1
band
verbatim
quote
After screening the essential ESCC-associated genes involved in both chemotherapy resistance and survival, least absolute shrinkage and selection operator (LASSO) Cox regression was performed to identify relevant risk genes, using 10-fold cross-validation, and the prognostic predictive signature, using the R software package glmnet (v 4.1-1).
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
KM
[2] object · 10 fields
id
method-3
family
survival_analysis
specific
log_rank_test
label
Survival analysis
dsl_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
parameters object · 2 fields
median_survival
The median survival of the low-DOCK8 group
confidence_interval
8 group was 1,361 days (95% CI: 754–1,968 days), while
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
logrank
[3] object · 10 fields
id
method-4
family
network_analysis
specific
ppi_network
label
Network / pathway analysis
dsl_operations array · 3 items
[0]
build_graph
[1]
centrality_scores
[2]
pathway_enrich
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
edge_list
evidence object · 3 fields
score
0.7
band
medium
quote
Protein-protein interaction
[4] object · 10 fields
id
method-5
family
network_analysis
specific
pathway_enrichment
label
Network / pathway analysis
dsl_operations array · 1 item
[0]
pathway_enrich
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
edge_list
evidence object · 3 fields
score
0.7
band
medium
quote
GO enrichment
targets array · 1 item
[0] object · 8 fields
id
target-published-estimate
claim_id
claim-target-result
operation
build_graph
unit
per cent
tolerance
null
state
complete
note
The published estimate as the reader quoted it from the paper. No tolerance is published because the paper states none.
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 2 items
[0]
GSE86099
[1]
GSE50224
resolved_accessions array · 2 items
[0]
GSE86099
[1]
GSE50224
statements array · 1 item
[0]
There were two available arrays with chemotherapy-resistant ESCC samples: GSE86099 (gene expression signature of paclitaxel resistance in human ESCC cell lines) and GSE50224 (the expression profiling of miRNA from chemotherapy-resistant esophageal adenosquamous carcinoma cell line).
basis
The paper names GSE86099, GSE50224 in Gene Expression Omnibus (GEO) database and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
cox_ph
assets array · 2 items
[0]
source:pmid:35282117
[1]
data:geo:GSE50224
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE50224
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T17:37:49Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
null
calls
5
usage object · 3 fields
prompt_tokens
11668
completion_tokens
1666
cached_tokens
128
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:35282117
type
paper
label
pmid:35282117
[1] object · 3 fields
id
source:pmid:35282117
type
manuscript
label
PMID 35282117 full text
[2] object · 3 fields
id
data:geo:GSE50224
type
dataset
label
GEO GSE50224
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:35282117
type
paper
label
pmid:35282117
[1] object · 3 fields
id
source:pmid:35282117
type
manuscript
label
PMID 35282117 full text
[2] object · 3 fields
id
data:geo:GSE50224
type
dataset
label
GEO GSE50224
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-35282117
type
extraction
used array · 1 item
[0]
source:pmid:35282117
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE50224
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE50224
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:35282117
parent_hash
sha256:7c8a3295272a9efe46c8c1bd5f5e0ac4de79105876e640feaf36540a721e60c2
fork_of
null
gaps array · 8 items
[0]
asset:data:geo:GSE50224 licence not read
[1]
asset:data:geo:GSE50224 not downloaded
[2]
asset:data:geo:GSE86099 licence not read
[3]
asset:data:geo:GSE86099 not downloaded
[4]
execution.not_run
[5]
review.human_critique
[6]
review.independent_reader
[7]
review.machine_critique
assays array · 3 items
[0] object · 11 fields
role
data_generation
definition_id
apoptosis_assay
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.69
evidence array · 1 item
[0]
rease of drug intake, the inhibition of cell apoptosis, and so on. This study aimed to investigate
order_basis
paper_text_order:641
id
assay:1
[1] object · 11 fields
role
data_generation
definition_id
rna_seq
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 2 items
[0]
ene expression data based on RNA sequencing (RNA-seq) and expressed as HTSeq-FPKM (Fragments Per
[1]
nts with clear gene expression data based on RNA sequencing (RNA-seq) and expressed as HTSeq-FPKM (Fragm
order_basis
paper_text_order:2742
id
assay:2
[2] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
cox_ph
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
After screening the essential ESCC-associated genes involved in both chemotherapy resistance and survival, least absolute shrinkage and selection operator (LASSO) Cox regression was performed to identify relevant risk genes, using 10-fold cross-validation, and the prognostic predictive signature, using the R software package glmnet (v 4.1-1).
order_basis
consumes_earlier_output
id
assay:3
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:35282117", "kind": "science-record", "revision": 4, "content_hash": "sha256:8e37b32070429b65bf6f06da6c30fa3342fd7e3ab8ec33b644671a7d9763f608", "created_at": "2026-11-01T18:14:04Z", "updated_at": "2026-11-01T22:06:06Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Analysis of cancer-promoting genes related to chemotherapy resistance in esophageal squamous cell carcinoma.", "doi": "10.21037/atm-21-7032", "pmid": "35282117", "authors": ["Feng Xie", "Donglei Zhang", "Xiaoqing Qian", "Huabing Wei", "Lihuang Zhou", "Chunyong Ding", "Wenbiao Pan", "Qing Ye"], "journal": "Annals of translational medicine", "year": 2022, "abstract": "Background: According to histopathology, esophageal cancer can be divided into squamous cell carcinoma (SCC) and esophageal adenocarcinoma (adeno arcinoma). In China, 90% of esophageal cancer patients are squamous cell carcinoma. Cisplatin and fluaziridine are the main chemotherapy before and after surgery. Long-term drug treatment is often accompanied by the emergence of drug resistance of tumor cells. There are many mechanisms for the emergence of drug resistance of tumor cells, including the increase of drug efflux, the decrease of drug intake, the inhibition of cell apoptosis, and so on. This study aimed to investigate the key cancer-promoting genes related to chemotherapy resistance in esophageal squamous cell carcinoma (ESCC).\nMethods: Two datasets from the Gene Expression Omnibus (GEO) database (GSE86099 and GSE50224) were retrieved. We performed microRNA (miRNA) and messenger RNA (mRNA) expression analysis to identify differentially expressed genes (DEGs). The intersection of the downregulated miRNA targets and the upregulated mRNAs were used for Gene Ontology (GO) enrichment analysis, and survival risk was assessed using data from The Cancer Genome Atlas (TCGA).\nResults: There were 35 common genes, of which, based on GO enrichment, most were related to the cardiac muscle cell action. Four genes showed significant association with the estimated half-maximal inhibitory concentration (IC50) of paclitaxel: bone morphogenetic protein 1 (BMP1), dumbbell former 4 protein (DBF4), angiogenin (ANG), and MAP7 domain containing 2 (MAP7D2). Four risk factors (MP1, HIP1, ANG, and MAP7D2) were selected to generate a signature using least absolute shrinkage and selection operator (LASSO) regression. Protein-protein interaction (PPI) analysis showed guanine nucleotide-binding protein subunit beta 4 (GNB4), calcium voltage-gated channel auxiliary subunit beta 2 (CACNB2), and sodium voltage-gated channel alpha subunit 1 (SCN1A) were located at key positions of the network. Among potential risk genes, only the high expression of dedicator of cytokinesis 8 (DOCK8) was associated with poorer survival.\nConclusions: The 35 oncogenes may be involved in mechanisms of chemotherapy resistance in ESCC, as well as the corresponding enrichment and regulatory network. The signature containing 4 key risk genes merits further investigation and may provide a deeper understanding of the molecular mechanisms in ESCC treatment failure.", "claims": [{"id": "claim-method", "statement": "After screening the essential ESCC-associated genes involved in both chemotherapy resistance and survival, least absolute shrinkage and selection operator (LASSO) Cox regression was performed to identify relevant risk genes, using 10-fold cross-validation, and the prognostic predictive signature, using the R software package glmnet (v 4.1-1).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:35282117", "locator": "sections[7] \"Prognostic predictive signature\" paragraph 2", "quote": "After screening the essential ESCC-associated genes involved in both chemotherapy resistance and survival, least absolute shrinkage and selection operator (LASSO) Cox regression was performed to identify relevant risk genes, using 10-fold cross-validation, and the prognostic predictive signature, using the R software package glmnet (v 4.1-1)."}], "state": "complete"}, {"id": "claim-data-access", "statement": "There were two available arrays with chemotherapy-resistant ESCC samples: GSE86099 (gene expression signature of paclitaxel resistance in human ESCC cell lines) and GSE50224 (the expression profiling of miRNA from chemotherapy-resistant esophageal adenosquamous carcinoma cell line).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:35282117", "locator": "sections[3] \"Microarray data\" paragraph 3", "quote": "There were two available arrays with chemotherapy-resistant ESCC samples: GSE86099 (gene expression signature of paclitaxel resistance in human ESCC cell lines) and GSE50224 (the expression profiling of miRNA from chemotherapy-resistant esophageal adenosquamous carcinoma cell line)."}], "state": "complete"}, {"id": "claim-target-result", "statement": "The four-gene risk signature achieved an AUC of 0.856 for 2-year survival prediction.", "kind": "quantitative", "target": {"value": 95.0, "unit": "per cent", "tolerance": null, "source": "In particular, the AUC value for the 2-year survival evaluation was 0.856 (95% CI: 0.742−0.969)."}, "evidence": [{"asset": "source:pmid:35282117", "locator": "sections[17] \"Prognostic performance of the signature\" paragraph 2", "quote": "In particular, the AUC value for the 2-year survival evaluation was 0.856 (95% CI: 0.742−0.969)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "The four-gene risk signature achieved an AUC of 0.856 for 2-year survival prediction.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:35282117"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE50224"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE50224"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:35282117", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.21037/atm-21-7032", "sha256": "sha256:545ee8603e691e1eba6cac667861c21b2e60a5c0503aaf7bdeb9edc158b12a08", "bytes": 39042, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.21037/atm-21-7032", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC8848450", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE50224", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE50224", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE50224", "version": null, "note": "There were two available arrays with chemotherapy-resistant ESCC samples: GSE86099 (gene expression signature of paclitaxel resistance in human ESCC cell lines) and GSE50224 (the expression profiling of miRNA from chemotherapy-resistant esophageal adenosquamous carcinoma cell line).", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "There were two available arrays with chemotherapy-resistant ESCC samples: GSE86099 (gene expression signature of paclitaxel resistance in human ESCC cell lines) and GSE50224 (the expression profiling of miRNA from chemotherapy-resistant esophageal adenosquamous carcinoma cell line).", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM1216060", "GSM1216061", "GSM1216062", "GSM1216063", "GSM1216064", "GSM1216065", "GSM1216066", "GSM1216067", "GSM1216068", "GSM1216069", "GSM1216070", "GSM1216071", "GSM1216072", "GSM1216073", "GSM1216074", "GSM1216075", "GSM1216076", "GSM1216077", "GSM1216078", "GSM1216079", "GSM1216080", "GSM1216081", "GSM1216082", "GSM1216083", "GSM1216084", "GSM1216085", "GSM1216086", "GSM1216087", "GSM1216088", "GSM1216089", "GSM1216090", "GSM1216091", "GSM1216092", "GSM1216093", "GSM1216094", "GSM1216095"], "sample_count": 36, "group_sizes": null, "group_sizes_basis": null, "platform": "8786", "taxon": "synthetic construct; Homo sapiens", "title": "MIcroRNA expression profiling of chemotherapy resistant esophageal adeno- and squamous cell carcinoma cell lines", "resolution_checked_at": "2026-11-01T18:06:44Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE86099", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE86099", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE86099", "version": null, "note": "There were two available arrays with chemotherapy-resistant ESCC samples: GSE86099 (gene expression signature of paclitaxel resistance in human ESCC cell lines) and GSE50224 (the expression profiling of miRNA from chemotherapy-resistant esophageal adenosquamous carcinoma cell line).", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "There were two available arrays with chemotherapy-resistant ESCC samples: GSE86099 (gene expression signature of paclitaxel resistance in human ESCC cell lines) and GSE50224 (the expression profiling of miRNA from chemotherapy-resistant esophageal adenosquamous carcinoma cell line).", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM2293542", "GSM2293543", "GSM2293544", "GSM2293545"], "sample_count": 4, "group_sizes": null, "group_sizes_basis": null, "platform": "4133", "taxon": "Homo sapiens", "title": "Gene expression signature of paclitaxel resistance in human esophageal squamous cell cancer cell line", "resolution_checked_at": "2026-11-01T15:39:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:GSE50224 not downloaded", "asset:data:geo:GSE50224 licence not read", "asset:data:geo:GSE86099 not downloaded", "asset:data:geo:GSE86099 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "After screening the essential ESCC-associated genes involved in both chemotherapy resistance and survival, least absolute shrinkage and selection operator (LASSO) Cox regression was performed to identify relevant risk genes, using 10-fold cross-validation, and the prognostic predictive signature, using the R software package glmnet (v 4.1-1)."}}, {"id": "method-2", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "KM"}}, {"id": "method-3", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {"median_survival": "The median survival of the low-DOCK8 group", "confidence_interval": "8 group was 1,361 days (95% CI: 754–1,968 days), while"}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "logrank"}}, {"id": "method-4", "family": "network_analysis", "specific": "ppi_network", "label": "Network / pathway analysis", "dsl_operations": ["build_graph", "centrality_scores", "pathway_enrich"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["edge_list"], "evidence": {"score": 0.7, "band": "medium", "quote": "Protein-protein interaction"}}, {"id": "method-5", "family": "network_analysis", "specific": "pathway_enrichment", "label": "Network / pathway analysis", "dsl_operations": ["pathway_enrich"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["edge_list"], "evidence": {"score": 0.7, "band": "medium", "quote": "GO enrichment"}}], "targets": [{"id": "target-published-estimate", "claim_id": "claim-target-result", "operation": "build_graph", "expected_value": 95.0, "unit": "per cent", "tolerance": null, "state": "complete", "note": "The published estimate as the reader quoted it from the paper. No tolerance is published because the paper states none."}], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["cox_ph"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE86099", "GSE50224"], "resolved_accessions": ["GSE86099", "GSE50224"], "statements": ["There were two available arrays with chemotherapy-resistant ESCC samples: GSE86099 (gene expression signature of paclitaxel resistance in human ESCC cell lines) and GSE50224 (the expression profiling of miRNA from chemotherapy-resistant esophageal adenosquamous carcinoma cell line)."], "basis": "The paper names GSE86099, GSE50224 in Gene Expression Omnibus (GEO) database and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["cox_ph"], "assets": ["source:pmid:35282117", "data:geo:GSE50224"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE50224"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T17:37:49Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": null}, "calls": 5, "usage": {"prompt_tokens": 11668, "completion_tokens": 1666, "cached_tokens": 128}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:35282117", "type": "paper", "label": "pmid:35282117"}, {"id": "source:pmid:35282117", "type": "manuscript", "label": "PMID 35282117 full text"}, {"id": "data:geo:GSE50224", "type": "dataset", "label": "GEO GSE50224"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:35282117", "type": "paper", "label": "pmid:35282117"}, {"id": "source:pmid:35282117", "type": "manuscript", "label": "PMID 35282117 full text"}, {"id": "data:geo:GSE50224", "type": "dataset", "label": "GEO GSE50224"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-35282117", "type": "extraction", "used": ["source:pmid:35282117"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE50224", "type": "accession_resolution", "used": ["data:geo:GSE50224"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:35282117", "parent_hash": "sha256:7c8a3295272a9efe46c8c1bd5f5e0ac4de79105876e640feaf36540a721e60c2", "fork_of": null, "generation": 3}, "gaps": ["asset:data:geo:GSE50224 licence not read", "asset:data:geo:GSE50224 not downloaded", "asset:data:geo:GSE86099 licence not read", "asset:data:geo:GSE86099 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "apoptosis_assay", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.69, "evidence": ["rease of drug intake, the inhibition of cell apoptosis, and so on. This study aimed to investigate"], "order_basis": "paper_text_order:641", "id": "assay:1"}, {"role": "data_generation", "definition_id": "rna_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["ene expression data based on RNA sequencing (RNA-seq) and expressed as HTSeq-FPKM (Fragments Per", "nts with clear gene expression data based on RNA sequencing (RNA-seq) and expressed as HTSeq-FPKM (Fragm"], "order_basis": "paper_text_order:2742", "id": "assay:2"}, {"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["cox_ph"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["After screening the essential ESCC-associated genes involved in both chemotherapy resistance and survival, least absolute shrinkage and selection operator (LASSO) Cox regression was performed to identify relevant risk genes, using 10-fold cross-validation, and the prognostic predictive signature, using the R software package glmnet (v 4.1-1)."], "order_basis": "consumes_earlier_output", "id": "assay:3"}]}